ATLANTA, GA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)ODYLIA THERAPEUTICS INC, founded in 2017, is a small nonprofit in the Medical Research sector that reported $571K in total revenue in fiscal year 2023. Revenue fell 48% from the prior year — a significant decline worth monitoring. Expenses of $867K exceeded revenue, resulting in a 52% operating deficit.
ODLYIA UTILIZES A UNIQUE, NON-PROFIT MODEL TO ACCELERATE THE DEVELOPMENT OF GENE THERAPIES FROM PEOPLE WITH RARE DISEASE, CHANGING THE WAY TREATMENTS ARE BROUGHT FROM THE LAB TO THE CLINIC.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $570,773 | $1,098,401 | -0.5% |
| Expenses | $867,236 | $866,473 | +0.0% |
| Net Income | $-296,463 | $231,928 | -2.3% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| ASHLEY WINSLOW | CEO/CSO | 40.00 |
Officer
|
$230,695 | $0 | $230,695 |
| JENNY KLEIN | MANAGER OF OPERATIONS & PROGRAM MANAGEMENT | 40.00 |
Highest
|
$109,099 | $0 | $109,099 |
| SCOTT DORFMAN | BOARD CHAIRMAN/TREASURER | 6.00 |
Officer
Director
|
$0 | $0 | $0 |
| SUSIE TROTOCHAUD | SECRETARY | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| KHANDAN BARADARAN | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| BRIAN FENTON | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| MATTHEW PLETCHER | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| LUK VANDENBERGH | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| GREG ROBINSON | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $570,773 | $867,236 | $9,688,644 | $-296,463 |
| 2022 | $1,098,401 | $866,473 | $10,021,651 | $231,928 |
| 2021 | $343,480 | $498,271 | $9,833,191 | $-154,791 |
| 2020 | $60,528 | $460,910 | $9,953,134 | $-400,382 |
| 2019 | $1,275,847 | $1,465,742 | $10,288,470 | $-189,895 |
| 2018 | $20,657,445 | $184,728 | $20,473,217 | $20,472,717 |
Compare ODYLIA THERAPEUTICS INC with other nonprofits in Georgia and across the country.